Ken Ohta

20.2k total citations · 1 hit paper
286 papers, 7.0k citations indexed

About

Ken Ohta is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology. According to data from OpenAlex, Ken Ohta has authored 286 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 121 papers in Pulmonary and Respiratory Medicine, 117 papers in Physiology and 69 papers in Immunology. Recurrent topics in Ken Ohta's work include Asthma and respiratory diseases (111 papers), Respiratory and Cough-Related Research (44 papers) and Mycobacterium research and diagnosis (41 papers). Ken Ohta is often cited by papers focused on Asthma and respiratory diseases (111 papers), Respiratory and Cough-Related Research (44 papers) and Mycobacterium research and diagnosis (41 papers). Ken Ohta collaborates with scholars based in Japan, United States and Germany. Ken Ohta's co-authors include Masao Yamaguchi, Hiroyuki Nagase, Koichi Hirai, Kazuhiko Yamamoto, Maho Suzukawa, Kouji Matsushima, Naomi Yamashita, William W. Busse, Mitchell Goldman and Magnus Aurivillius and has published in prestigious journals such as The Lancet, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Ken Ohta

262 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

2016 984 citations Ken Ohta, Magnus Aurivillius et al. profile →

Peers

Countries citing papers authored by Ken Ohta

Since Specialization

Citations

This map shows the geographic impact of Ken Ohta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Ohta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Ohta more than expected).

Fields of papers citing papers by Ken Ohta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Ohta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Ohta. The network helps show where Ken Ohta may publish in the future.

Co-authorship network of co-authors of Ken Ohta

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Ohta. A scholar is included among the top collaborators of Ken Ohta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Ohta. Ken Ohta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk factors, molecular analysis and treatment outcomes of amikacin-resistant Mycobacterium avium complex pulmonary disease 2025 ·ERJ Open Research ·Tatsuya Kodama, Akio Aono, Keiji Fujiwara, Koji Furuuchi, Masashi Ito, Keisuke Kamada, (unknown), (unknown), Yuriko Igarashi, Yoshiro Murase, Hideo Ogata, Yuji Shiraishi, Takashi Yoshiyama, Ken Ohta, Satoshi Mitarai, Kozo Morimoto	0
2	Epidemiological trends and clinical relevance of nontuberculous mycobacterial pulmonary disease in a referral hospital in Japan, 2017–2021 2024 ·Respiratory Investigation ·Masashi Ito, Koji Furuuchi, Keiji Fujiwara, Tatsuya Kodama, (unknown), Takashi Yoshiyama, Hideo Ogata, Atsuyuki Kurashima, Ken Ohta, Kozo Morimoto	0
3	Assessment of health-related quality of life in patients with nontuberculous mycobacterial pulmonary disease: A comprehensive review 2024 ·Respiratory Investigation ·(unknown), (unknown), Ken Ohta, Kozo Morimoto	0
4	Identification of exhaled volatile organic compounds that characterize asthma phenotypes: A J-VOCSA study 2024 ·Allergology International ·Maho Suzukawa, Ken Ohta, M. Sugimoto, Nobuharu Ohshima, Nobuyuki Kobayashi, Hiroyuki Tashimo, Yasushi Tanimoto, (unknown), Goro Kimura, Shohei Takata, Takako Nakano, Takafumi Yamashita, Satoshi Ikegame, (unknown), Masahiro Abe, (unknown), Yosuke Kamide, Kazunori Sasaki, Hiroya Hashimoto	2
5	Serum Derivatives–Reactive Oxygen Metabolite Levels as a Marker of Clinical Conditions in Patients with Bronchial Asthma, COPD, or Asthma–COPD Overlap: A Prospective Study 2024 ·Journal of Clinical Medicine ·Keitaro Nakamoto, Masato Watanabe, (unknown), (unknown), (unknown), Yuki Yoshida, Fumi Kobayashi, (unknown), (unknown), (unknown), Manabu Ishida, Mitsuru Sada, Kojiro Honda, Saori Takata, Takeshi Saraya, Masafumi Shimoda, Yoshiaki Tanaka, (unknown), Ken Ohta, Haruyuki Ishii	2
6	Beyond Symptoms: Radiologic identification of asymptomatic Mycobacterium avium complex pulmonary infections 2024 ·Respiratory Medicine ·Keiji Fujiwara, (unknown), (unknown), Koji Furuuchi, Masashi Ito, Tatsuya Kodama, (unknown), Takashi Yoshiyama, Satoshi Mitarai, Atsuyuki Kurashima, Ken Ohta, Kozo Morimoto	2
7	Diagnostic flowchart for tuberculous pleurisy, pleural infection, and malignant pleural effusion 2023 ·Respiratory Investigation ·Masafumi Shimoda, (unknown), Kozo Morimoto, Takashi Yoshiyama, Kozo Yoshimori, Ken Ohta	3
8	Multiple bacterial culture positivity reflects the severity and prognosis as bronchiectasis in Mycobacterium avium complex pulmonary disease 2023 ·Respiratory Medicine ·Masashi Ito, Koji Furuuchi, Keiji Fujiwara, (unknown), Tatsuya Kodama, (unknown), (unknown), Takashi Yoshiyama, Atsuyuki Kurashima, Ken Ohta, Kozo Morimoto	3
9	Identification of ANXA2 on epithelial cells as a new receptor for secretory IgA using immunoprecipitation and mass spectrometry 2022 ·Clinical & Experimental Immunology ·(unknown), Koichi S. Kobayashi, Maho Suzukawa, (unknown), (unknown), (unknown), Masashi Kitani, Takeshi Fukami, Takahide Nagase, Ken Ohta	4
10	Epidemiological characteristics of nontuberculous mycobacteriosis and bronchiectasis: comparative study using national mortality statistics from 1970 to 2015 in Japan 2022 ·ERJ Open Research ·Kozo Morimoto, Kazuro Iwai, Takashi Yoshiyama, Masashi Ito, (unknown), Takanori Asakura, Takeshi Osawa, Koji Furuuchi, Atsuyuki Kurashima, Keiji Fujiwara, Naoki Hasegawa, Yoshiaki Tanaka, Shoji Kudoh, Yuji Shiraishi, Satoshi Mitarai, Manabu Ato, Ken Ohta	4
11	Potential Cross-Transmission of Mycobacterium abscessus among Non-Cystic Fibrosis Patients at a Tertiary Hospital in Japan 2022 ·Microbiology Spectrum ·Keiji Fujiwara, Mitsunori Yoshida, Yoshiro Murase, Akio Aono, Koji Furuuchi, (unknown), Ken Ohta, Manabu Ato, Satoshi Mitarai, Kozo Morimoto	17
12	Molecular Epidemiology of Drug-Resistant Mycobacterium Tuberculosis in Japan 2021 ·mSphere ·Fuminori Mizukoshi, Nobuyuki Kobayashi, Fumiko Kirikae, Ken Ohta, Kazunari Tsuyuguchi, (unknown), Yoshikazu Inoue, Masahide Horiba, (unknown), (unknown), Tohru Miyoshi‐Akiyama, (unknown), Keiji Funatogawa, Teruo Kirikae	5
13	ABSTRACT WITHDRAWN 2019 ·Respirology ·Keitaro Nakamoto, Yuka Sasaki, Tatsuya Shirai, Keiji Fujiwara, Koji Furuuchi, Takeshi Osawa, Masafumi Shimoda, Kozo Morimoto, Yoshiaki Tanaka, Ken Ohta, Takashi Yoshiyama, Hideo Ogata, Atsuyuki Kurashima, Kozo Yoshimori	0
14	Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan 2019 ·Respiratory Medicine ·Koji Furuuchi, Kozo Morimoto, Takashi Yoshiyama, Yoshiaki Tanaka, Keiji Fujiwara, Masao Okumura, Kiyohiko Izumi, Yuji Shiraishi, Satoshi Mitarai, Hideo Ogata, Atsuyuki Kurashima, Kozo Yoshimori, Ken Ohta, Hajime Goto, Yuka Sasaki	57
15	The Role of FeNO in Cough Management : A Randomised Controlled Trial 2018 ·Aberdeen University Research Archive (Aberdeen University) ·David Price, Rikke Buhl, Adrian Chan, Daryl Freeman, Elizabeth Gardener, (unknown), Kevin Gruffydd‐Jones, Lorcan McGarvey, Ken Ohta, Dermot Ryan, (unknown), Ngiap Chuan Tan, Benita Kiat Tee Tan, Mike Thomas, Sen Yang, (unknown), Marcus Ngantcha, Martina Stagno d’Alcontres, Thérèse Lapperre	1
16	Benralizumab Reduces Exacerbations in Japanese Patients with Severe, Uncontrolled Asthma: Subgroup Analysis of the Calima Trial 2017 ·Journal of Allergy and Clinical Immunology ·J Mark FitzGerald, Ken Ohta, Mitsuru Adachi, Yuji Tohda, Tadashi Kamei, Motokazu Kato, (unknown), (unknown), Nobuyuki Imai, Yanping Wu, Magnus Aurivillius, Mitchell Goldman	1
17	Chronic Thromboembolic Pulmonary Hypertension Complicated by a Cavitating Lung Infection Caused by <i>Mycobacterium intracellulare</i> 2014 ·Internal Medicine ·Kenichi Okuda, Hirotoshi Matsui, Junko Suzuki, Nobuharu Ohshima, Kimihiko Masuda, Akira Yamane, Atsuhisa Tamura, Hideaki Nagai, Shinobu Akagawa, Ken Ohta	2
18	[A multicenter, open-label, randomized comparison of suppressive effects on asthmatic inflammation of lower airways and improved effects on health-related QOL between HFA-BDP and fluticasone propionate]. 2007 ·PubMed ·Hiroyuki Ohbayashi, Mitsuru Adachi, Masakazu Ichinose, Ken Ohta, Fumio Kokubu, Yasuyuki Sano, Gen Tamura, Yuji Tohda, Kazuto Hirata, Hirotaka Yasuba	2
19	Trans-basement membrane migration of human basophils: role of matrix metalloproteinase-9 2006 ·International Immunology ·Maho Suzukawa, Akiko Komiya, Motoyasu Iikura, Hiroyuki Nagase, (unknown), Hirokazu Yamada, Hiroshi Kawasaki, Ken Ohta, Koji Matsushima, Koichi Hirai, Kota Yamamoto, Mai Yamaguchi	19
20	[A case of dermatomyositis which rapidly developed to respiratory failure in the presence of pneumomediastinum]. 1989 ·PubMed ·Nobuyuki Kobayashi, Hajime Takizawa, Haruhito Sugiyama, Makoto Dohi, Akira Ishii, Ken Ohta, Matsunobu Suko, (unknown), Kiyoaki Tanimoto, Hirokazu Okudaira, Koji Ito, Terumasa Miyamoto	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact